Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KNSAKiniksa Pharmaceuticals International, plc

Nasdaq · CIK 0001730430
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts266

Identity from submissions API

NameKiniksa Pharmaceuticals International, plc
CIK0001730430
TickersKNSA
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN981795578
LEI—
Fiscal year end1231
State of incorporation—
Phone7814319100
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Kiniksa Pharmaceuticals, Ltd. (2018-02-27T05:00:00.000Z → 2024-06-28T04:00:00.000Z)
Business address
105 PICCADILLY, SECOND FLOOR
LONDON
W1J 7NJ
United Kingdom
X0
Mailing address
105 PICCADILLY, SECOND FLOOR
LONDON
W1J 7NJ
United Kingdom
X0

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

780 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 xslF345X06/form4-11172026_091158.xml 0001741533-26-000014 21709
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128329 005-90491 261561056 34 10994
2026-11-12 4 xslF345X06/form4-11122026_091151.xml 0001464583-26-000012 9531
2026-11-06 4 xslF345X06/form4-11062026_091108.xml 0001532218-26-000020 18901
2026-11-03 4 xslF345X06/form4-11042026_121101.xml 0001532218-26-000018 49290
2026-11-03 4 xslF345X06/form4-11032026_111136.xml 0001835458-26-000014 27118
2026-11-03 4 xslF345X06/form4-11032026_111150.xml 0001741533-26-000012 37840
2026-11-03 4 xslF345X06/form4-11032026_111116.xml 0001857177-26-000010 59048
2026-11-03 4 xslF345X06/form4-11032026_111101.xml 0001464583-26-000010 32433
2026-11-02 144 xsl144X01/primary_doc.xml 0001921094-26-001138 001-38492 261513562 33 4552
2026-10-30 144 xsl144X01/primary_doc.xml 0001921094-26-001129 001-38492 261509376 33 6095
2026-10-30 144 xsl144X01/primary_doc.xml 0001921094-26-001127 001-38492 261509362 33 5815
2026-10-30 144 xsl144X01/primary_doc.xml 0001921094-26-001126 001-38492 261509359 33 5927
2026-10-30 144 xsl144X01/primary_doc.xml 0001921094-26-001125 001-38492 261509357 33 4760
2026-10-27 10-Q 10-Q 0001104659-26-119186 001-38492 261491085 34 9397451 1 1
2026-10-27 8-K 8-K 2.02,9.01 0001730430-26-000037 001-38492 261487336 34 397925 1 1
2026-10-22 8-K 8-K 5.02 0001730430-26-000034 001-38492 261479148 34 144563 1 1
2026-09-03 4 xslF345X06/form4-09032026_080953.xml 0001835458-26-000012 24941
2026-09-03 4 xslF345X06/form4-09032026_080911.xml 0001532218-26-000016 26800
2026-09-03 4 xslF345X06/form4-09032026_080914.xml 0001532218-26-000014 26800
2026-09-03 4 xslF345X06/form4-09032026_080907.xml 0001741533-26-000010 25061
2026-09-03 4 xslF345X06/form4-09032026_080952.xml 0001857177-26-000008 24960
2026-09-03 4 xslF345X06/form4-09032026_080913.xml 0001464583-26-000008 28402
2026-09-03 144 xsl144X01/primary_doc.xml 0001921094-26-000988 001-38492 261358248 33 4503
2026-08-21 4 xslF345X06/form4-08212026_080804.xml 0001384243-26-000014 5184
2026-08-04 4 xslF345X06/form4-08042026_080829.xml 0001454983-26-000008 9518
2026-07-31 4 xslF345X06/form4-07312026_080745.xml 0001337798-26-000004 6633
2026-07-29 144 xsl144X01/primary_doc.xml 0001921094-26-000768 001-38492 261217321 33 5278
2026-07-29 144 xsl144X01/primary_doc.xml 0001921094-26-000767 001-38492 261217294 33 4962
2026-07-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002783 005-90491 261216882 34 11294
2026-07-28 10-Q 10-Q 0001104659-26-087545 001-38492 261212081 34 9034250 1 1
2026-07-28 8-K 8-K 2.02,9.01 0001730430-26-000031 001-38492 261207538 34 368674 1 1
2026-07-06 4 xslF345X06/form4-07062026_080742.xml 0002143491-26-000004 18749
2026-07-06 3 xslF345X06/form3-07062026_080749.xml 0002143491-26-000002 11795
2026-06-02 4 xslF345X06/form4-06022026_080623.xml 0001384243-26-000012 12287
2026-06-02 4 xslF345X06/form4-06022026_080611.xml 0001333482-26-000002 21067
2026-06-02 4 xslF345X06/form4-06022026_080657.xml 0001532218-26-000012 9223
2026-06-02 4 xslF345X06/form4-06022026_080613.xml 0001683600-26-000002 20843
2026-06-02 4 xslF345X06/form4-06022026_080631.xml 0001403322-26-000002 21819
2026-06-02 4 xslF345X06/form4-06022026_080618.xml 0001454983-26-000004 21099
2026-06-02 4 xslF345X06/form4-06022026_080647.xml 0001337798-26-000002 20717
2026-06-02 4 4 0001193125-26-253615 29519
2026-05-29 8-K 8-K 5.07 0001730430-26-000029 001-38492 261045276 34 206324 1 1
2026-05-26 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-066339 005-90491 261020967 34 34391
2026-05-26 8-K 8-K 1.01,9.01 0001730430-26-000025 001-38492 261020826 34 241324 1 1
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001224 005-90491 26946811 34 11621
2026-05-05 4 xslF345X06/form4-05052026_080527.xml 0001741533-26-000008 11420
2026-05-01 144 xsl144X01/primary_doc.xml 0001921094-26-000432 001-38492 26933441 33 5295
2026-05-01 8-K 8-K 5.02 0001730430-26-000021 001-38492 26933147 34 144830 1 1
2026-05-01 4 xslF345X06/form4-05012026_080517.xml 0001532218-26-000008 11595
2026-04-30 4 xslF345X06/form4-04302026_100400.xml 0001532218-26-000006 32238
2026-04-29 4 xslF345X06/form4-04292026_080403.xml 0001384243-26-000010 9357
2026-04-28 144 xsl144X01/primary_doc.xml 0001921094-26-000422 001-38492 26908787 33 5353
2026-04-28 10-Q 10-Q 0001104659-26-050359 001-38492 26908038 34 7794124 1 1
2026-04-28 8-K 8-K 2.02,9.01 0001730430-26-000017 001-38492 26903152 34 312022 1 1
2026-04-16 ARS ARS 0001104659-26-044418 001-38492 26868033 34 3100829
2026-04-16 DEFA14A DEFA14A 0001104659-26-044412 001-38492 26867993 34 505034
2026-04-16 DEF 14A DEF 14A 0001104659-26-044410 001-38492 26867980 34 6654829 1 1
2026-04-13 4 xslF345X06/form4-04132026_080442.xml 0001464583-26-000006 5175
2026-04-13 4 xslF345X06/form4-04132026_080438.xml 0001857177-26-000006 5225
2026-04-09 144 xsl144X01/primary_doc.xml 0001921094-26-000387 001-38492 26851557 33 5152
2026-04-09 144 xsl144X01/primary_doc.xml 0001921094-26-000386 001-38492 26851546 33 5098
2026-04-08 4 xslF345X06/form4-04082026_080406.xml 0001867899-26-000004 9051
2026-04-08 4 xslF345X06/form4-04082026_080407.xml 0001835458-26-000010 8954
2026-04-08 4 xslF345X06/form4-04082026_080403.xml 0001532218-26-000004 16315
2026-04-08 4 xslF345X06/form4-04082026_080454.xml 0001741533-26-000006 9059
2026-04-08 4 xslF345X06/form4-04082026_080439.xml 0001857177-26-000004 19430
2026-04-08 4 xslF345X06/form4-04082026_080417.xml 0001464583-26-000004 8954
2026-04-08 4 xslF345X06/form4-04082026_080443.xml 0001384243-26-000008 9350
2026-04-06 144 xsl144X01/primary_doc.xml 0001921094-26-000372 001-38492 26841916 33 7781
2026-04-06 144 xsl144X01/primary_doc.xml 0001921094-26-000371 001-38492 26841903 33 4726
2026-04-06 144 xsl144X01/primary_doc.xml 0001921094-26-000368 001-38492 26841141 33 4529
2026-04-03 4 xslF345X06/form4-04032026_080412.xml 0001867899-26-000002 22853
2026-04-03 4 xslF345X06/form4-04032026_080402.xml 0001835458-26-000008 20929
2026-04-03 4 xslF345X06/form4-04032026_080457.xml 0001532218-26-000002 22524
2026-04-03 4 xslF345X06/form4-04032026_080425.xml 0001741533-26-000004 21035
2026-04-03 4 xslF345X06/form4-04032026_080450.xml 0001857177-26-000002 22750
2026-04-03 4 xslF345X06/form4-04032026_080430.xml 0001464583-26-000002 22718
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001633 005-90491 26801852 34 7318
2026-03-11 4 xslF345X05/form4-03112026_080357.xml 0001835458-26-000006 22919
2026-03-09 144 xsl144X01/primary_doc.xml 0001921094-26-000294 001-38492 26736250 33 5805
2026-03-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000640 005-90491 26728942 34 11755
2026-03-04 4 xslF345X05/form4-03042026_090352.xml 0001741533-26-000002 13138
2026-03-02 144 xsl144X01/primary_doc.xml 0001921094-26-000239 001-38492 26709498 33 4663
2026-02-24 S-8 FORM S-8 0001104659-26-019184 333-293695 26672531 33 290913 1 1
2026-02-24 10-K 10-K 0001104659-26-019168 001-38492 26672380 34 15891498 1 1
2026-02-24 8-K 8-K 2.02,9.01 0001730430-26-000014 001-38492 26667539 34 330113 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015194 005-90491 26632723 34 10790
2026-02-12 4 xslF345X05/form4-02122026_090237.xml 0001384243-26-000004 13915
2026-02-11 4 xslF345X05/form4-02112026_090228.xml 0001835458-26-000004 14753
2026-02-04 4 xslF345X05/form4-02042026_110219.xml 0001384243-26-000002 20330
2026-02-04 4 xslF345X05/form4-02042026_110254.xml 0001454983-26-000002 9312
2026-01-14 8-K 8-K 5.02 0001730430-26-000010 001-38492 26533624 34 143594 1 1
2026-01-12 8-K 8-K 2.02,9.01 0001730430-26-000005 001-38492 26527815 34 217467 1 1
2026-01-09 4 xslF345X05/form4-01092026_090138.xml 0001835458-26-000002 5416
2025-12-17 4 xslF345X05/form4-12172025_091228.xml 0001384243-25-000004 17724
2025-12-17 4 xslF345X05/form4-12172025_091235.xml 0001867899-25-000013 9265
2025-12-15 144 xsl144X01/primary_doc.xml 0001921094-25-001555 001-38492 251572477 33 4646
2025-12-10 4 xslF345X05/form4-12102025_101258.xml 0001835458-25-000007 17245
2025-12-08 144 xsl144X01/primary_doc.xml 0001921094-25-001502 001-38492 251556878 33 6569
2025-12-01 4 xslF345X05/form4-12012025_091206.xml 0001867899-25-000011 8860
2025-11-26 144 xsl144X01/primary_doc.xml 0001921094-25-001432 001-38492 251531539 33 10306
2025-11-19 4 xslF345X05/form4-11192025_091118.xml 0001867899-25-000009 11192
2025-11-17 144 xsl144X01/primary_doc.xml 0001921094-25-001388 001-38492 251491845 33 10199
2025-11-14 4 xslF345X05/form4-11142025_091149.xml 0001532218-25-000007 10081
2025-11-14 4 xslF345X05/form4-11142025_091151.xml 0001835458-25-000005 9134
2025-11-04 4 xslF345X05/form4-11042025_091113.xml 0001741533-25-000003 21718
2025-10-31 144 xsl144X01/primary_doc.xml 0001921094-25-001307 001-38492 251441444 33 5224
2025-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000265 005-90491 251438834 34 6287
2025-10-30 4 xslF345X05/form4-10302025_081002.xml 0001835458-25-000003 17153
2025-10-28 144 xsl144X01/primary_doc.xml 0001921094-25-001299 001-38492 251425624 33 5188
2025-10-28 144 xsl144X01/primary_doc.xml 0001921094-25-001298 001-38492 251425615 33 5188
2025-10-28 10-Q 10-Q 0001104659-25-103180 001-38492 251425024 34 9991599 1 1
2025-10-28 8-K FORM 8-K 2.02,9.01 0001104659-25-102834 001-38492 251421451 34 278536 1 1
2025-10-22 4 xslF345X05/form4-10222025_091005.xml 0001532218-25-000005 31561
2025-10-22 4 xslF345X05/form4-10222025_091045.xml 0001464583-25-000005 25610
2025-10-20 144 xsl144X01/primary_doc.xml 0001921094-25-001280 001-38492 251404962 33 4561
2025-10-20 144 xsl144X01/primary_doc.xml 0001921094-25-001279 001-38492 251404960 33 7075
2025-10-16 4 xslF345X05/form4-10162025_041001.xml 0001867899-25-000007 19848
2025-10-14 144 xsl144X01/primary_doc.xml 0001921094-25-001257 001-38492 251392405 33 10655
2025-10-08 4 xslF345X05/form4-10082025_081015.xml 0001464583-25-000003 17174
2025-10-01 4 xslF345X05/form4-10012025_081048.xml 0001867899-25-000005 9163
2025-09-29 144 xsl144X01/primary_doc.xml 0001921094-25-001213 001-38492 251357389 33 8906
2025-09-17 4 xslF345X05/form4-09172025_080944.xml 0001867899-25-000003 11082
2025-09-15 144 xsl144X01/primary_doc.xml 0001921094-25-001156 001-38492 251315114 33 10668
2025-09-08 4 xslF345X05/form4-09082025_080944.xml 0001415889-25-023878 18432
2025-09-08 4 xslF345X05/form4-09082025_080945.xml 0001415889-25-023874 4920
2025-09-05 144 xsl144X01/primary_doc.xml 0001921094-25-001103 001-38492 251297200 33 10136
2025-09-04 144 xsl144X01/primary_doc.xml 0001921094-25-001088 001-38492 251294082 33 9617
2025-09-04 144 xsl144X01/primary_doc.xml 0001921094-25-001087 001-38492 251294075 33 5042
2025-09-03 4 xslF345X05/form4-09032025_090925.xml 0001415889-25-023587 35709
2025-09-03 144 xsl144X01/primary_doc.xml 0001921094-25-001079 001-38492 251290662 33 8989
2025-09-03 4 xslF345X05/form4-09032025_080915.xml 0001415889-25-023564 31904
2025-09-03 4 xslF345X05/form4-09032025_080909.xml 0001415889-25-023557 26133
2025-09-03 4 xslF345X05/form4-09032025_080906.xml 0001415889-25-023555 26229
2025-09-03 4 xslF345X05/form4-09032025_080932.xml 0001415889-25-023553 26112
2025-09-03 4 xslF345X05/form4-09032025_080927.xml 0001415889-25-023550 26893
2025-09-03 144 xsl144X01/primary_doc.xml 0001921094-25-001072 001-38492 251289987 33 5720
2025-09-03 8-K FORM 8-K 7.01,9.01 0001104659-25-086689 001-38492 251287757 34 8248262 1 1
2025-08-20 4 xslF345X05/form4-08202025_080850.xml 0001415889-25-022460 10680
2025-08-18 144 xsl144X01/primary_doc.xml 0001921094-25-000981 001-38492 251228805 33 10691
2025-08-14 4 xslF345X05/form4-08142025_080859.xml 0001415889-25-021941 35056
2025-08-14 144 xsl144X01/primary_doc.xml 0001921094-25-000954 001-38492 251220148 33 5648
2025-08-13 144 xsl144X01/primary_doc.xml 0001921094-25-000947 001-38492 251212038 33 5026
2025-08-12 144 xsl144X01/primary_doc.xml 0001921094-25-000930 001-38492 251207601 33 4406
2025-08-08 4 xslF345X05/form4-08082025_040802.xml 0001415889-25-021346 9178
2025-08-07 4 xslF345X05/form4-08072025_080818.xml 0001415889-25-021271 28689
2025-08-06 144 xsl144X01/primary_doc.xml 0001921094-25-000890 001-38492 251190824 33 5219
2025-08-06 4 xslF345X05/form4-08062025_040802.xml 0001415889-25-021178 8857
2025-08-06 4 xslF345X05/form4-08062025_040801.xml 0001415889-25-021177 11044
2025-08-05 144 xsl144X01/primary_doc.xml 0001921094-25-000879 001-38492 251186250 33 8309
2025-08-04 144 xsl144X01/primary_doc.xml 0001921094-25-000868 001-38492 251180338 33 5107
2025-08-04 144 xsl144X01/primary_doc.xml 0001921094-25-000867 001-38492 251180328 33 5720
2025-08-01 4 xslF345X05/form4-08012025_080803.xml 0001415889-25-020866 12354
2025-07-30 144 xsl144X01/primary_doc.xml 0001950047-25-005261 001-38492 251167024 33 5372
2025-07-29 10-Q 10-Q 0001558370-25-009738 001-38492 251162074 34 9978502 1 1
2025-07-29 8-K FORM 8-K 2.02,9.01 0001104659-25-071413 001-38492 251157562 34 275008 1 1
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002968 005-90491 251132119 34 11134
2025-07-16 4 xslF345X05/form4-07162025_040704.xml 0001415889-25-019841 9166
2025-07-14 144 xsl144X01/primary_doc.xml 0001921094-25-000783 001-38492 251122356 33 11758
2025-07-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-066696 005-90491 251113665 34 10709
2025-07-03 4 xslF345X05/form4-07032025_080736.xml 0001415889-25-019334 9215
2025-06-18 4 xslF345X05/form4-06182025_080651.xml 0001415889-25-017691 9168
2025-06-16 144 xsl144X01/primary_doc.xml 0001921094-25-000686 001-38492 251051158 33 10559
2025-06-11 4 xslF345X05/form4-06112025_090650.xml 0001415889-25-016724 19335
2025-06-11 4 xslF345X05/form4-06112025_090628.xml 0001415889-25-016722 20368
2025-06-11 144 xsl144X01/primary_doc.xml 0001921094-25-000655 001-38492 251040564 33 7056
2025-06-10 144 xsl144X01/primary_doc.xml 0001921094-25-000648 001-38492 251038268 33 7055
2025-06-09 144 xsl144X01/primary_doc.xml 0001921094-25-000638 001-38492 251034980 33 6437
2025-06-09 144 xsl144X01/primary_doc.xml 0001921094-25-000637 001-38492 251034969 33 4466
2025-06-05 4 xslF345X05/form4-06052025_090634.xml 0001415889-25-015805 11948
2025-06-05 4 4 0000950170-25-082485 28967
2025-06-05 4 xslF345X05/form4-06052025_090611.xml 0001415889-25-015800 11969
2025-06-05 4 xslF345X05/form4-06052025_090659.xml 0001415889-25-015796 12913
2025-06-05 4 xslF345X05/form4-06052025_080654.xml 0001415889-25-015792 11987
2025-06-05 4 xslF345X05/form4-06052025_080613.xml 0001415889-25-015788 11958
2025-06-05 4 xslF345X05/form4-06052025_080657.xml 0001415889-25-015784 11980
2025-06-05 4 xslF345X05/form4-06052025_080606.xml 0001415889-25-015782 9033
2025-06-05 4 xslF345X05/form4-06052025_080613.xml 0001415889-25-015780 9080
2025-06-05 4 xslF345X05/form4-06052025_080632.xml 0001415889-25-015778 8660
2025-06-05 8-K FORM 8-K 7.01,9.01 0001104659-25-056665 001-38492 251025017 34 6999920 1 1
2025-06-03 144 xsl144X01/primary_doc.xml 0001921094-25-000594 001-38492 251020229 33 5706
2025-06-03 144 xsl144X01/primary_doc.xml 0001921094-25-000593 001-38492 251020217 33 7606
2025-06-03 144 xsl144X01/primary_doc.xml 0001921094-25-000592 001-38492 251020192 33 8863
2025-06-03 8-K FORM 8-K 5.07 0001104659-25-055990 001-38492 251020091 34 230281 1 1
2025-05-28 4 xslF345X05/form4-05282025_050501.xml 0001415889-25-014744 21012
2025-05-28 DEFA14A DEFA14A 0001104659-25-053649 001-38492 25996603 34 32111
2025-05-22 4 xslF345X05/form4-05222025_080524.xml 0001415889-25-014167 9824
2025-05-21 4 xslF345X05/form4-05212025_080502.xml 0001415889-25-013944 9163
2025-05-19 144 xsl144X01/primary_doc.xml 0001921094-25-000525 001-38492 25965074 33 6375
2025-05-15 4 xslF345X05/form4-05152025_080533.xml 0001415889-25-013170 9824
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-048493 005-90491 25945244 34 10690
2025-05-09 4 xslF345X05/form4-05092025_090511.xml 0001415889-25-012571 20231
2025-05-09 4 xslF345X05/form4-05092025_090502.xml 0001415889-25-012541 8761
2025-05-09 4 xslF345X05/form4-05092025_080544.xml 0001415889-25-012532 16221
2025-05-09 DEFA14A DEFA14A 0001104659-25-046775 001-38492 25930990 34 1338269 1 1
2025-05-07 144 xsl144X01/primary_doc.xml 0001921094-25-000442 001-38492 25922705 33 4649
2025-05-07 144 xsl144X01/primary_doc.xml 0001921094-25-000441 001-38492 25922506 33 4684
2025-05-07 144 xsl144X01/primary_doc.xml 0001921094-25-000439 001-38492 25921095 33 5041
2025-05-05 4 xslF345X05/form4-05052025_080547.xml 0001415889-25-011992 25351
2025-05-05 4 xslF345X05/form4-05052025_080511.xml 0001415889-25-011988 13855
2025-05-05 4 xslF345X05/form4-05052025_080516.xml 0001415889-25-011985 13719
2025-05-05 4 xslF345X05/form4-05052025_080539.xml 0001415889-25-011981 13693
2025-05-05 4 xslF345X05/form4-05052025_080509.xml 0001415889-25-011979 13771
2025-05-05 4 xslF345X05/form4-05052025_080539.xml 0001415889-25-011975 13862
2025-05-05 144 xsl144X01/primary_doc.xml 0001921094-25-000437 001-38492 25913053 33 6978
2025-05-02 144 xsl144X01/primary_doc.xml 0001921094-25-000432 001-38492 25909720 33 6355
2025-05-01 4 xslF345X05/form4-05012025_100513.xml 0001415889-25-011692 38036
2025-05-01 4 xslF345X05/form4-05012025_100529.xml 0001415889-25-011690 27064
2025-05-01 144 xsl144X01/primary_doc.xml 0001921094-25-000422 001-38492 25904310 33 8234
2025-05-01 144 xsl144X01/primary_doc.xml 0001921094-25-000421 001-38492 25904302 33 5733
2025-04-30 144 xsl144X01/primary_doc.xml 0001921094-25-000419 001-38492 25896024 33 7608
2025-04-29 4 xslF345X05/form4-04292025_080403.xml 0001415889-25-011502 8645
2025-04-29 144 xsl144X01/primary_doc.xml 0001921094-25-000415 001-38492 25888207 33 5109
2025-04-29 144 xsl144X01/primary_doc.xml 0001921094-25-000414 001-38492 25888189 33 6982
2025-04-29 10-Q 10-Q 0001558370-25-005847 001-38492 25887799 34 8284757 1 1
2025-04-29 8-K FORM 8-K 2.02,9.01 0001104659-25-040641 001-38492 25882698 34 300506 1 1
2025-04-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001430 005-90491 25863138 34 11139
2025-04-23 4 xslF345X05/form4-04232025_080423.xml 0001415889-25-011209 5317
2025-04-23 8-K FORM 8-K 5.02,9.01 0001104659-25-038041 001-38492 25862025 34 518071 1 1
2025-04-21 DEFA14A DEFA14A 0001104659-25-036929 001-38492 25854513 34 1248267
2025-04-21 ARS ARS 0001104659-25-036856 001-38492 25853765 34 28938010
2025-04-21 DEF 14A DEF 14A 0001104659-25-036852 001-38492 25853714 34 7051072 1 1
2025-04-21 144 xsl144X01/primary_doc.xml 0001921094-25-000404 001-38492 25853181 33 4571
2025-04-16 4 xslF345X05/form4-04162025_080444.xml 0001415889-25-010808 11088
2025-04-14 144 xsl144X01/primary_doc.xml 0001921094-25-000393 001-38492 25836592 33 6375
2025-04-10 PRE 14A PRE 14A 0001104659-25-033788 001-38492 25828909 34 7187846 1 1
2025-04-09 4 xslF345X05/form4-04092025_080449.xml 0001415889-25-010487 8748
2025-04-09 4 xslF345X05/form4-04092025_080402.xml 0001415889-25-010485 8650
2025-04-09 4 xslF345X05/form4-04092025_080409.xml 0001415889-25-010482 9405
2025-04-09 4 xslF345X05/form4-04092025_080424.xml 0001415889-25-010480 8754
2025-04-09 4 xslF345X05/form4-04092025_080436.xml 0001415889-25-010478 8658
2025-04-09 4 xslF345X05/form4-04092025_080447.xml 0001415889-25-010476 8613
2025-04-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-005483 005-90491 25816083 34 29948
2025-04-03 4 xslF345X05/form4-04032025_090416.xml 0001415889-25-010012 21297
2025-04-03 4 xslF345X05/form4-04032025_090458.xml 0001415889-25-010007 21394
2025-04-03 4 xslF345X05/form4-04032025_090414.xml 0001415889-25-010004 21288
2025-04-03 4 xslF345X05/form4-04032025_090432.xml 0001415889-25-009998 21388
2025-04-03 4 xslF345X05/form4-04032025_090418.xml 0001415889-25-009993 22057
2025-04-03 4 xslF345X05/form4-04032025_080410.xml 0001415889-25-009991 18559
2025-03-24 4 xslF345X05/form4-03242025_080343.xml 0001415889-25-008846 9265
2025-03-19 4 xslF345X05/form4-03192025_090329.xml 0001415889-25-008622 19858
2025-03-19 4 xslF345X05/form4-03192025_090322.xml 0001415889-25-008620 10475
2025-03-19 4 xslF345X05/form4-03192025_090332.xml 0001415889-25-008618 10427
2025-03-19 4 xslF345X05/form4-03192025_090333.xml 0001415889-25-008616 8753
2025-03-19 4 xslF345X05/form4-03192025_090332.xml 0001415889-25-008614 9412
2025-03-19 4 xslF345X05/form4-03192025_090338.xml 0001415889-25-008612 8759
2025-03-17 144 xsl144X01/primary_doc.xml 0001921094-25-000327 001-38492 25745749 33 5199
2025-03-14 4 xslF345X05/form4-03142025_080322.xml 0001415889-25-008117 9224
2025-03-14 4 xslF345X05/form4-03142025_080318.xml 0001415889-25-008115 9272
2025-03-12 144 xsl144X01/primary_doc.xml 0001921094-25-000309 001-38492 25732369 33 4417
2025-03-12 4 xslF345X05/form4-03122025_080305.xml 0001415889-25-007814 9173
2025-03-12 144 xsl144X01/primary_doc.xml 0001921094-25-000308 001-38492 25731687 33 4485
2025-03-10 144 xsl144X01/primary_doc.xml 0001921094-25-000301 001-38492 25724779 33 7000
2025-02-25 S-8 FORM S-8 0001104659-25-016951 333-285211 25663845 33 149821
2025-02-25 10-K 10-K 0001558370-25-001505 001-38492 25663435 34 14896187 1 1
2025-02-25 8-K FORM 8-K 1.02,2.02,2.05,9.01 0001104659-25-016725 001-38492 25659409 34 326584 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014002 005-90491 25627704 34 15199
2025-02-12 4 xslF345X05/form4-02122025_090204.xml 0001415889-25-003748 9173
2025-02-10 144 xsl144X01/primary_doc.xml 0001921094-25-000106 001-38492 25606883 33 7000
2025-01-15 4 xslF345X05/form4-01152025_090106.xml 0001415889-25-001496 11098
2025-01-13 144 xsl144X01/primary_doc.xml 0001921094-25-000035 001-38492 25527146 33 7000
2025-01-13 8-K FORM 8-K 2.02,9.01 0001104659-25-002858 001-38492 25524818 34 263541 1 1
2024-12-18 4 xslF345X05/form4-12182024_091234.xml 0001415889-24-029747 9173
2024-12-16 144 xsl144X01/primary_doc.xml 0001921094-24-001649 001-38492 241552811 33 7003
2024-12-10 4 xslF345X05/form4-12102024_091222.xml 0001415889-24-028844 15132
2024-12-05 4 xslF345X05/form4-12062024_121225.xml 0001415889-24-028431 20456
2024-12-03 144 xsl144X01/primary_doc.xml 0001921094-24-001523 001-38492 241523798 33 4569
2024-12-02 4 xslF345X05/form4-12022024_091211.xml 0001415889-24-027993 14402
2024-11-27 144 xsl144X01/primary_doc.xml 0001921094-24-001495 001-38492 241512385 33 4525
2024-11-20 4 xslF345X05/form4-11202024_091114.xml 0001415889-24-027354 9180
2024-11-18 144 xsl144X01/primary_doc.xml 0001921094-24-001433 001-38492 241472650 33 7003
2024-11-14 SC 13G/A KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC 0000902664-24-006617 005-90491 241463253 34 58259
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118928 005-90491 241462493 34 105436
2024-11-13 SC 13G/A SC 13G/A 0001104659-24-117745 005-90491 241454875 34 72336
2024-11-12 4 xslF345X05/form4-11122024_091100.xml 0001415889-24-026617 9226
2024-11-08 SC 13G gb00brxb0c07_110824.txt 0002012383-24-004025 005-90491 241442061 34 14053
2024-11-08 4 xslF345X05/form4-11082024_091109.xml 0001415889-24-026451 9834
2024-11-06 144 xsl144X01/primary_doc.xml 0001921094-24-001356 001-38492 241431046 33 4565
2024-10-29 10-Q 10-Q 0001558370-24-013840 001-38492 241405882 34 8720982 1 1
2024-10-29 8-K FORM 8-K 2.02,9.01 0001104659-24-112034 001-38492 241402698 34 281183 1 1
2024-10-21 SC 13G gb00brxb0c07_102124.txt 0002012383-24-000920 005-90491 241383566 34 14041
2024-10-17 4 xslF345X05/form4-10172024_081035.xml 0001415889-24-025374 9179
2024-10-15 144 xsl144X01/primary_doc.xml 0001921094-24-001291 001-38492 241372457 33 6385
2024-10-08 SC 13D/A SC 13D/A 0001104659-24-107086 005-90491 241361026 34 123086
2024-10-08 3 3 0000950170-24-113576 2997
2024-10-08 4 xslF345X05/form4-10082024_081027.xml 0001415889-24-024885 8610
2024-10-08 4 4 0000950170-24-113535 30231
2024-10-07 8-K FORM 8-K 5.02 0001104659-24-106690 001-38492 241358219 34 199600 1 1
2024-09-25 4 xslF345X05/form4-09252024_080916.xml 0001415889-24-023954 9178
2024-09-23 144 xsl144X01/primary_doc.xml 0001921094-24-001232 001-38492 241316813 33 5767
2024-09-04 4 xslF345X05/form4-09052024_120905.xml 0001415889-24-022861 22662
2024-09-04 4 xslF345X05/form4-09052024_120917.xml 0001415889-24-022857 21662
2024-09-04 4 xslF345X05/form4-09052024_120923.xml 0001415889-24-022862 20983
2024-09-04 4 xslF345X05/form4-09052024_120908.xml 0001415889-24-022856 32398
2024-09-04 4 xslF345X05/form4-09052024_120941.xml 0001415889-24-022859 20874
2024-09-04 4 xslF345X05/form4-09052024_120928.xml 0001415889-24-022854 38344
2024-09-03 144 xsl144X01/primary_doc.xml 0001921094-24-001149 001-38492 241275061 33 4494
2024-09-03 144 xsl144X01/primary_doc.xml 0001921094-24-001148 001-38492 241275047 33 5231
2024-08-29 4 xslF345X05/form4-08292024_080838.xml 0001415889-24-022560 9178
2024-08-27 144 xsl144X01/primary_doc.xml 0001921094-24-001117 001-38492 241250047 33 5098
2024-07-25 4 xslF345X05/form4-07252024_080727.xml 0001415889-24-020108 13258
2024-07-25 4 xslF345X05/form4-07252024_080736.xml 0001415889-24-020106 9275
2024-07-25 4 xslF345X05/form4-07252024_080729.xml 0001415889-24-020104 14558
2024-07-25 10-Q 10-Q 0001558370-24-010181 001-38492 241142151 34 9345429 1 1
2024-07-23 144 xsl144X01/primary_doc.xml 0001921094-24-000950 001-38492 241134908 33 4454
2024-07-23 144 xsl144X01/primary_doc.xml 0001921094-24-000949 001-38492 241134904 33 4535
2024-07-23 15-15D/A 15-15D/A 0001104659-24-081920 333-264746 241134903 34 14740
2024-07-23 144 xsl144X01/primary_doc.xml 0001921094-24-000948 001-38492 241134901 33 4568
2024-07-23 8-K FORM 8-K 2.02,9.01 0001104659-24-081717 001-38492 241132955 34 318107 1 1
2024-07-03 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-03 16:00:00 9999999995-24-002070 333-280611 241101566 33 1873
2024-07-03 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-24-076396,2024-07-03 9999999995-24-002060 333-264751 241101556 33 1886
2024-07-02 CORRESP filename1.htm 0001104659-24-077357 12008
2024-07-02 UPLOAD filename1.pdf 0000000000-24-007541 333-280611 40224
2024-06-28 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-24-075846,2024-06-28 9999999995-24-002008 333-264746 241087720 33 1886
2024-06-28 15-15D 15-15D 0001104659-24-076411 333-264746 241087091 34 12378
2024-06-28 S-3 S-3 0001104659-24-076409 333-280611 241087080 33 990635
2024-06-28 S-8 POS S-8 POS 0001104659-24-076403 333-277480 241087029 33 135093
2024-06-28 S-8 POS S-8 POS 0001104659-24-076402 333-270226 241087019 33 135083
2024-06-28 S-8 POS S-8 POS 0001104659-24-076401 333-262971 241087013 33 135341
2024-06-28 S-8 POS S-8 POS 0001104659-24-076400 333-253514 241087008 33 135341
2024-06-28 S-8 POS S-8 POS 0001104659-24-076399 333-237589 241086997 33 135341
2024-06-28 S-8 POS S-8 POS 0001104659-24-076398 333-225196 241086988 33 135071
2024-06-28 POS AM POS AM 0001104659-24-076396 333-264751 241086976 33 406114
2024-06-28 8-K12B 8-K12B 1.01,3.01,3.02,3.03,5.02,5.03,8.01,9.01 0001104659-24-076282 001-38492 241085878 34 4181878 1 1
2024-06-28 POS AM POS AM 0001104659-24-075846 333-264746 241081121 33 23959
2024-06-25 8-K FORM 8-K 1.01,9.01 0001104659-24-074763 001-38492 241069345 34 202479 1 1
2024-06-14 8-K FORM 8-K 8.01 0001104659-24-071787 001-38492 241045255 34 201543 1 1
2024-06-07 4 xslF345X05/form4-06072024_080618.xml 0001415889-24-016009 11559
2024-06-07 4 xslF345X05/form4-06072024_080609.xml 0001415889-24-016006 11581
2024-06-07 4 xslF345X05/form4-06072024_080658.xml 0001415889-24-016002 12522
2024-06-07 4 xslF345X05/form4-06072024_080650.xml 0001415889-24-016000 11598
2024-06-07 4 xslF345X05/form4-06072024_080618.xml 0001415889-24-015997 11569
2024-06-07 4 xslF345X05/form4-06072024_080604.xml 0001415889-24-015994 11614
2024-06-07 4 4 0000950170-24-070612 28266
2024-06-05 8-K FORM 8-K 5.07 0001104659-24-068694 001-38492 241022344 34 214512 1 1
2024-05-29 DEFA14A DEFA14A 0001104659-24-066165 001-38492 24999700 34 33690
2024-05-07 4 xslF345X05/form4-05072024_080507.xml 0001415889-24-012480 9131
2024-04-30 4 xslF345X05/form4-04302024_080421.xml 0001415889-24-011764 8571
2024-04-25 10-Q 10-Q 0001558370-24-005774 001-38492 24876530 34 7657964 1 1
2024-04-23 DEFA14A DEFA14A 0001104659-24-050633 001-38492 24865430 34 368585
2024-04-23 DEFA14A DEFA14A 0001104659-24-050630 001-38492 24865398 34 444476
2024-04-23 ARS ARS 0001104659-24-050626 001-38492 24865370 34 3173479
2024-04-23 DEF 14A DEF 14A 0001104659-24-050621 001-38492 24865322 34 7463702 1 1
2024-04-23 8-K FORM 8-K 2.02,9.01 0001104659-24-050335 001-38492 24862704 34 301310 1 1
2024-04-10 PRE 14A PRE 14A 0001104659-24-045880 001-38492 24836486 34 7428752 1 1
2024-04-08 4 xslF345X05/form4-04082024_090415.xml 0001415889-24-010514 16718
2024-04-08 4 xslF345X05/form4-04082024_090412.xml 0001415889-24-010511 16062
2024-04-08 4 xslF345X05/form4-04082024_090417.xml 0001415889-24-010509 15942
2024-04-08 4 xslF345X05/form4-04082024_090417.xml 0001415889-24-010507 15966
2024-04-08 4 xslF345X05/form4-04082024_090419.xml 0001415889-24-010505 13229
2024-04-08 4 xslF345X05/form4-04082024_090409.xml 0001415889-24-010503 16056
2024-04-05 SC 13G/A bmg5269c1010_040424.txt 0001086364-24-007379 005-90491 24825618 34 13639
2024-04-03 4 xslF345X05/form4-04032024_090446.xml 0001415889-24-010091 8571
2024-04-03 4 xslF345X05/form4-04032024_090445.xml 0001415889-24-010088 8671
2024-04-03 4 xslF345X05/form4-04032024_090440.xml 0001415889-24-010086 9333
2024-04-03 4 xslF345X05/form4-04032024_090431.xml 0001415889-24-010084 8535
2024-04-03 4 xslF345X05/form4-04032024_090405.xml 0001415889-24-010079 8580
2024-04-03 4 xslF345X05/form4-04032024_090447.xml 0001415889-24-010077 8676
2024-04-02 8-K FORM 8-K 7.01,9.01 0001104659-24-042231 001-38492 24812228 34 11054984 1 1
2024-03-29 DEFA14A DEFA14A 0001104659-24-041196 001-38492 24804660 34 53304
2024-03-29 DEFA14A DEFA14A 0001104659-24-040848 001-38492 24802009 34 106692
2024-03-29 8-K FORM 8-K 8.01,9.01 0001104659-24-040847 001-38492 24802007 34 303330 1 1
2024-03-11 4 xslF345X05/form4-03112024_110346.xml 0001415889-24-007569 6747
2024-03-06 4 xslF345X05/form4-03062024_100330.xml 0001415889-24-007083 9904
2024-03-05 4 xslF345X05/form4-03052024_090322.xml 0001415889-24-006702 9094
2024-03-05 4 xslF345X05/form4-03052024_090325.xml 0001415889-24-006674 9100
2024-03-04 144 xsl144X01/primary_doc.xml 0001921094-24-000318 001-38492 24717147 33 4590
2024-03-01 4 xslF345X05/form4-03012024_110310.xml 0001415889-24-006170 20016
2024-03-01 144 xsl144X01/primary_doc.xml 0001921094-24-000302 001-38492 24711792 33 5167
2024-02-29 4 xslF345X05/form4-02292024_090213.xml 0001415889-24-005883 9101
2024-02-28 S-8 S-8 0001104659-24-028816 333-277480 24697330 33 107000
2024-02-28 144 xsl144X01/primary_doc.xml 0001921094-24-000273 001-38492 24696561 33 5775
2024-02-28 10-K 10-K 0001558370-24-002005 001-38492 24695603 34 13371129 1 1
2024-02-28 8-K FORM 8-K 2.02,9.01 0001104659-24-028472 001-38492 24690190 34 312788 1 1
2024-02-27 144 xsl144X01/primary_doc.xml 0001921094-24-000267 001-38492 24688228 33 5253
2024-02-14 SC 13G/A KINIKSA PHARMACEUTICALS, LTD. 0000902664-24-001735 005-90491 24639469 34 59698
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023533 005-90491 24637098 34 110985
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021288 005-90491 24628757 34 13090
2024-02-12 SC 13G SC 13G 0001104659-24-013554 005-90491 24617243 34 73983
2024-01-25 SC 13G bmg5269c1010_012524.txt 0001086364-24-003309 005-90491 24561085 34 13532
2024-01-04 4 xslF345X05/form4-01042024_040113.xml 0001415889-24-000609 8591
2024-01-04 4 xslF345X05/form4-01042024_040110.xml 0001415889-24-000608 8959
2024-01-04 8-K FORM 8-K 2.02,7.01,9.01 0001104659-24-001149 001-38492 24509769 34 17821866 1 1
2024-01-03 144 xsl144X01/primary_doc.xml 0001921094-24-000017 001-38492 24507744 33 4391
2024-01-02 UPLOAD filename1.pdf 0000000000-24-000003 39925
2023-12-21 4 xslF345X05/form4-12212023_091222.xml 0001415889-23-016827 8518
2023-12-19 144 xsl144X01/primary_doc.xml 0001921094-23-001110 001-38492 231498363 33 4463
2023-12-11 4 xslF345X05/form4-12112023_041201.xml 0001415889-23-016183 14780
2023-12-08 CORRESP filename1.htm 0001104659-23-124696 45354
2023-12-07 144 xsl144X01/primary_doc.xml 0001921094-23-001013 001-38492 231472904 33 4424
2023-11-21 CORRESP filename1.htm 0001104659-23-120401 13677
2023-11-16 UPLOAD filename1.pdf 0000000000-23-012553 44482
2023-11-07 4 xslF345X05/form4-11072023_091100.xml 0001415889-23-014841 9061
2023-11-02 10-Q 10-Q 0001558370-23-017423 001-38492 231372515 34 8610820 1 1
2023-10-31 8-K FORM 8-K 2.02,9.01 0001104659-23-112750 001-38492 231362304 34 306377 1 1
2023-10-06 4 xslF345X05/form4-10062023_081034.xml 0001415889-23-014037 8446
2023-09-06 4 xslF345X05/form4-09062023_110926.xml 0001415889-23-013048 20213
2023-09-06 4 xslF345X05/form4-09062023_110933.xml 0001415889-23-013046 20255
2023-09-06 4 xslF345X05/form4-09062023_110936.xml 0001415889-23-013044 19940

Latest XBRL company facts

One latest value per concept from companyfacts (266 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 1.11B 2025-06-30 2025 FY 10-K 2026-02-24 0001104659-26-019168
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 677.56M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001104659-26-044410
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 8.23M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001104659-26-044410
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.51M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001104659-26-044410
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001104659-26-044410
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 28.44M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001104659-26-044410
ecd PeoTotalCompAmt PeoTotalCompAmt USD 10.78M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001104659-26-044410
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 233.45 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001104659-26-044410
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.11M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 30.78M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 57.70M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 9.05M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AccruedRentNoncurrent Accrued Rent, Noncurrent USD 144,000 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 7.52M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.75M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.08B 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD -3.00M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 13.06M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AdvertisingExpense Advertising Expense USD 12.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 34.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 750,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap Assets Assets USD 983.24M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AssetsCurrent Assets, Current USD 750.10M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 125,000 2025-12-31 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3.26M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 497.94M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 1,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-04-25 0001558370-24-005774
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 9,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-04-25 0001558370-24-005774
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 224.55M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 487.10M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 262.55M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 494.68M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 78.83M 2024-03-31 2024 Q1 10-Q 2024-04-25 0001558370-24-005774
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 91,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 81.66M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 414.07M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 81.66M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -83.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 210,000 2020-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 54.65M 2018-05-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 92.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 7.66M 2022-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 12.26M 2023-12-31 2024 FY 10-K 2025-02-25 0001558370-25-001505
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 307,000 2023-12-31 2024 FY 10-K 2025-02-25 0001558370-25-001505
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 31.81M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -37.08M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-25 0001558370-25-001505
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 22.89M 2017-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 72.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 16.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 16.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 78.84M 2024-03-31 2024 Q1 10-Q 2024-04-25 0001558370-24-005774
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 0 2024-03-31 2024 Q1 10-Q 2024-04-25 0001558370-24-005774
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 2.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 15.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 198.04M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 619,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 733.22M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 866.91M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 188,000 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 1.22M 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 198.15M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 109.36M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 4.09M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 13.33M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 4.60M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 666.46M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.30M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 8.56M 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 237,000 2023-12-31 2024 FY 10-K 2025-02-25 0001558370-25-001505
us-gaap DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries USD 15.14M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 2.31M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 3.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap Depreciation Depreciation USD 490,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap DividendsCash Dividends, Cash USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-05 0001558370-19-009978
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 0 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 1.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.78 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 1.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.335 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.25 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -16.577 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.359 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001558370-23-002684
us-gaap EffectiveIncomeTaxRateReconciliationFdiiPercent EffectiveIncomeTaxRateReconciliationFdiiPercent pure -0.022 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.216 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.026 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.048 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.02 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.123 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal Effective Income Tax Rate Reconciliation, Tax Contingency, State and Local, Percent pure -0.02 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-25 0001558370-25-001505
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.089 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 26.59M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 34.82M 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 9.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-04 0001558370-22-012203
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-06-30 2022 Q2 10-Q 2022-08-04 0001558370-22-012203
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 4.75M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 10.25M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 1.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 250,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 1.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 1.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 1.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 20.00M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 14.50M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 24,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 20.60M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006256
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 2.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 122.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 86.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -156.23M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap IncomeTaxesPaid Income Taxes Paid USD 482,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 27.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 22.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 10.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 15.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 49.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD -7.66M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 19.55M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 53.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -394,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 26.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -228,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 21.13M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap InventoryNet Inventory, Net USD 108.03M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 15.27M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 76.25M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 11.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LeaseCost Lease, Cost USD 5.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 10.48M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.48M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 80,000 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 193,000 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.56M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.16M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 932,000 2023-09-30 2023 Q3 10-Q 2023-11-02 0001558370-23-017423
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 983,000 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap Liabilities Liabilities USD 273.05M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 983.24M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap LiabilitiesCurrent Liabilities, Current USD 191.85M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 15.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -244.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 144.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 95.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OperatingExpenses Operating Expenses USD 49.28M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001558370-21-006256
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 110.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OperatingLeaseCost Operating Lease, Cost USD 4.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 9.50M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.97M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.92M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.39M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 4.19M 2018-12-31 2019 FY 10-K 2020-03-05 0001558370-20-002081
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.39M 2018-12-31 2019 FY 10-K 2020-03-05 0001558370-20-002081
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 972,000 2018-12-31 2019 FY 10-K 2020-03-05 0001558370-20-002081
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.82M 2018-12-31 2019 FY 10-K 2020-03-05 0001558370-20-002081
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 935,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.07 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 442,000 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 10.75M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 20.26M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 45.47M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap OtherNoncashExpense Other Noncash Expense USD 235,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 12.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-04 0001558370-20-005040
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-04 0001558370-20-005040
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.14M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-02 0001558370-23-002684
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 14.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 20.00M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 457.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 42.53M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 1.83M 2018-09-30 2018 Q3 10-Q 2018-11-06 0001558370-18-008650
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 155.54M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 165.72M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 55.94M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 30.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 214.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 25,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2.88M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 95.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 9.98M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.46M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 215.63M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 101.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 210,000 2019-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -366.77M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 743.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap Revenues Revenues USD 743.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 684,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001558370-23-008113
us-gaap RoyaltyExpense Royalty Expense USD 835,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001558370-22-001932
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 190.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 34.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 213,494 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 12.27 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.39M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 15.13 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 2.40M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 14 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 521,440 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 15.18M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 13.6 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-10-29 0001558370-24-013840
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.762 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.01 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 37.61M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 7.35M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 13.59 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 2.60M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 359,281 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.13M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 11.60M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 13.67 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 54.65M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 11.60M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 13.67 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8.99 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 15.06 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 14.69 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap ShortTermInvestments Short-term Investments USD 487.10M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 15,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 710.19M 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 2.732 2018-05-11 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 319,829 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 7.00M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-24 0001558370-22-001932
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 310.59M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001558370-21-001821
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 6.07M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 155.54M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 331,000 2020-07-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 119.77M 2017-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 120.00M 2017-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2019-12-31 2019 FY 10-K 2020-03-05 0001558370-20-002081
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2019-12-31 2019 FY 10-K 2020-03-05 0001558370-20-002081
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 22.89M 2017-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 50.47M 2023-12-31 2023 FY 10-K 2024-02-28 0001558370-24-002005
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 32.67M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 102,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 1.12M 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-12 0001558370-19-001857
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 19.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 122,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 9.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap VariableLeaseCost Variable Lease, Cost USD 894,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001104659-26-019168
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 83.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 68.44M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001558370-21-014650
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 77.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-10-27 0001104659-26-119186

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →